-
-
-
-
-
-
-
InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
-
-
-
-
-
-
-
InflaRx N.V. (IFRX) Misses Q2 EPS by 4c
-
-
-
-
-
-
-
InflaRx Reports Second Quarter 2023 Financial Results & Operating Update
-
-
-
-
-
-
-
InflaRx Reports Q2 2020 Financial & Operating Results
-
-
-
-
-
-
-
InflaRx Full Year 2018 Financial & Operating Results
-
-
1,198,727 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

